TI
ALDR

Trexquant Investment’s Alder Biopharmaceuticals ALDR Stock Holding History

Trexquant Investment’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-19,637
Closed -$231K – 1237
2019
Q2 		$231K Buy
+19,637
New +$238K 0.02% 659
2019
Q1 		– Sell
-17,345
Closed -$178K – 1463
2018
Q4 		$178K Buy
+17,345
New +$222K 0.01% 938
2017
Q2 		– Sell
-12,726
Closed -$265K – 1339
2017
Q1 		$265K Buy
+12,726
New +$282K 0.03% 821
2016
Q1 		– Sell
-10,191
Closed -$337K – 1286
2015
Q4 		$337K Sell
10,191
-42,990
-81% -$1.45M 0.03% 809
2015
Q3 		$1.74M Buy
53,181
+43,181
+432% +$1.84M 0.15% 204
2015
Q2 		$529K Sell
10,000
-18,300
-65% -$666K 0.06% 591
2015
Q1 		$816K Buy
+28,300
New +$777K 0.08% 470

Other funds holding ALDR

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Trexquant Investment's ALDR Position: Q3 2019 in Review

Trexquant Investment sold out of Alder Biopharmaceuticals (ALDR) in Q3 2019, closing a stake of 19,637 shares — an estimated $231K sold.

Trexquant Investment first reported a position in ALDR in Q1 2015 and held it in 7 quarters. The position peaked at $1.74M in Q3 2015. 143 funds tracked by Wall St. Rank hold ALDR as of Q3 2019.

  • Trexquant Investment reported no remaining Alder Biopharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Trexquant Investment sold 19,637 Alder Biopharmaceuticals shares in Q3 2019, an estimated $231K.
  • Trexquant Investment first reported a position in Alder Biopharmaceuticals in Q1 2015 and held it in 7 quarters.
  • Trexquant Investment's Alder Biopharmaceuticals position peaked at $1.74M in Q3 2015.
  • 143 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q3 2019.

Based on Trexquant Investment's 13F filing for Q3 2019, filed 8 Nov 2019.